News | February 25, 2022
Canada approves plant-based Covid-19 vaccine
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2
The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth
100% efficacy against severe Covid-19 disease and hospitalizations
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
Collaboration in the industry needs to be institutionalised to drive the growth.
he financing was significantly oversubscribed with high demand from both existing and new investors.
The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
Subscribe To Our Newsletter & Stay Updated
